NCT04457856 - A Study of TJ003234 in Rheumatoid Arthritis Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 6, 2020

Primary Completion Date

March 31, 2023

Study Completion Date

March 31, 2023

Conditions

Rheumatoid Arthritis

Interventions

BIOLOGICAL

TJ003234 injection

Intravenous administration, single dose (0.3-1-3-10mg/kg) or multiple dose (1-3-6mg/kg, once every week, for 8 weeks)

Trial Locations (5)

RECRUITING

Peking university people's Hospital, Beijing

RECRUITING

The first affiliated hospital of bengbu medical college, Bengbu

RECRUITING

Nanjing Drum Tower Hospital, Nanjing

RECRUITING

Zhongda Hospital southeast university, Nanjing

RECRUITING

FuDan University shanghai huashan Hospital, Shanghai